Φορτώνει......
The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
BACKGROUND: The treatment of migraine is impeded by several difficulties, among which insufficient headache relief, side effects, and risk for developing medication overuse headache (MOH). Thus, new acutely acting antimigraine drugs are currently being developed, among which the small molecule CGRP...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Headache Pain |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Milan
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734450/ https://ncbi.nlm.nih.gov/pubmed/31096904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-019-1007-y |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|